VYNE Therapeutics Inc. - VYNE

All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)? Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).

Files summary

Total files loaded: 18
Latest filed: May 21, 2026
Form Count
4 12
8-K 5
SCHEDULE 13G 1

Latest files

Filed Form Report period Accession SEC
May 21, 2026 8-K May 21, 2026 0001104659-26-065214 View
May 15, 2026 SCHEDULE 13G 0001104659-26-062664 View
Apr 02, 2026 4 Mar 31, 2026 0001727794-26-000004 View
Apr 02, 2026 4 Mar 31, 2026 0001727809-26-000004 View
Apr 02, 2026 4 Mar 31, 2026 0001727756-26-000004 View
Apr 02, 2026 4 Mar 31, 2026 0001867033-26-000004 View
Mar 11, 2026 8-K Mar 11, 2026 0001104659-26-026439 View
Jan 30, 2026 8-K Jan 30, 2026 0001104659-26-008642 View
Jan 05, 2026 4 Dec 31, 2025 0001727809-26-000002 View
Jan 05, 2026 4 Dec 31, 2025 0001727756-26-000002 View
Jan 05, 2026 4 Dec 31, 2025 0001867033-26-000002 View
Jan 05, 2026 4 Dec 31, 2025 0001727794-26-000002 View
Dec 17, 2025 8-K Dec 17, 2025 0001104659-25-121828 View
Dec 15, 2025 4 Dec 12, 2025 0001240499-25-000004 View
Dec 15, 2025 4 Dec 12, 2025 0001417397-25-000004 View
Dec 15, 2025 4 Dec 12, 2025 0001055404-25-000004 View
Dec 15, 2025 4 Dec 12, 2025 0001632295-25-000005 View
Dec 12, 2025 8-K Dec 12, 2025 0001104659-25-120637 View